-
-
-
-
-
-
-
Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion
-
-
-
-
-
-
-
Form 4 Petra Acquisition Inc. For: Sep 21 Filed by: GLAZER CAPITAL, LLC
-
-
-
-
-
-
-
Form 4 Petra Acquisition Inc. For: Nov 09 Filed by: GLAZER CAPITAL, LLC
-
1,181,588 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

